
无数据
无数据
无数据
| CAS Number | 13292-46-1 |
| Catalog Number | AG00397J(AGN-PC-00S7WO) |
| Chemical Name | 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin |
| EC Number | 236-312-0 |
| IUPAC Name | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate |
| InChI | InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1 |
| InChI Key | JQXXHWHPUNPDRT-WLSIYKJHSA-N |
| MDL Number | MFCD00151389 |
| Molecular Formula | C43H58N4O12 |
| Molecular Weight | 822.9402 |
| NSC Number | 113926 |
| SMILES | OC1=C(/C=N/N2CCN(C)CC2)C3=C(O)C4=C(O)C(C)=C(O[C@@](O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(C)/C(N3)=O)(C)C5=O)C5=C41 |
| UNII | VJT6J7R4TR |
| Synonyms | Benemycin,
Rifadin,
Rifampicin,
Rifampin,
Rimactan,
Rimactane,
Tubocin,
Rifampicin,
rifampin,
Rifadin,
Rimactane,
Rimactan,
Rifamycin AMP,
Rifaldazine,
Rifampicinum,
Rifaprodin,
Riforal,
Tubocin,
Rifa,
13292-46-1,
Archidyn,
Rifoldin,
Rifoldine,
Rimactizid,
Rifagen,
Rimazid,
Rifampicin SV,
R/AMP,
Rifampicina,
Arficin,
Benemicin,
Doloresum,
Eremfat,
Fenampicin,
Rifadine,
Rifaldazin,
Rifaldin,
Rifamor,
Rifinah,
Rifobac,
Rimactazid,
Sinerdol,
Arzide,
Rifcin,
Rifam,
L-5103 Lepetit,
Dione 21-acetate,
Rifampicine [French],
Abrifam,
Rifampicinum [INN-Latin],
Ba 41166/E,
Rifampicina [INN-Spanish],
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV,
CCRIS 551,
Rifadin I.V.,
HSDB 3181,
UNII-VJT6J7R4TR,
BA-41166E,
NSC113926,
VJT6J7R4TR,
Rifampicine,
Rifampicin [INN:BAN:JAN],
Rifamycin, 3-(((4-methyl-1-piperazinyl)imino)methyl)-,
RFP,
CHEBI:28077,
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV,
8-(4-Methylpiperazinyliminomethyl) rifamycin SV,
L-5103,
C43H58N4O12,
EINECS 236-312-0,
Rifamate,
NSC 113926,
NSC-113926,
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV,
Rifamycin, 3-[[(4-methyl-1-piperazinyl)imino]methyl]-,
Rifomycin SV, 8-(N-(4-methyl-1-piperazinyl)formidoyl)-,
DSSTox_CID_1244,
DSSTox_RID_76035,
DSSTox_GSID_21244,
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate,
Famcin,
RIF,
Benemycin,
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate,
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate,
CAS-13292-46-1,
3-(4-Methylpiperazinyliminomethyl)rifamycin SV,
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin,
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin,
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV,
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv,
rifamcin,
[1,11,13]trienimino)naphto[2,1-b]furan-21-yl acetate,
Rifomycin sv, 8-[N-(4-Methyl-1-piperazinyl)formidoyl]-,
JQXXHWHPUNPDRT-WLSIYKJHSA-N,
Rifamsolin,
Dipicin,
Rimycin,
DRG-0109,
MFCD00151389,
MMV688775,
Rifamicin AMP,
Rifadin I.V,
Rimactane (TN),
NCGC00094777-01,
AZT + Rifampin,
Rifampin (USP),
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[[(4-methylpiperazin-1-yl)imino]methyl]-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca,
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acet,
(2S,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-Pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate,
[pentahydroxy-methoxy-heptamethyl-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-dioxo-[?]yl] acetate,
Rifampicin & EEP,
Rifampin [USAN],
Prestwick_833,
R-Cin,
Rifadin (TN),
Piperine & Rifampicin,
Rifampicin & Propolis,
Reserpine & Rifampicin,
Rifampin [USAN:USP],
Prestwick2_000525,
Prestwick3_000525,
Spectrum5_002018,
Rifampicin (JP17/INN),
SCHEMBL23490,
BSPBio_000509,
L-5103-LEPETIT,
8CI),
BPBio1_000561,
CHEMBL374478,
DTXSID6021244,
HMS1569J11,
HMS2089F12,
HMS2096J11,
HMS3713J11,
Rifampicin, >=97.0% (HPLC),
Rifampicin, powder, gamma-irradiated,
Tox21_111329,
Tox21_201385,
Tox21_300550,
Ba 41166,
BDBM50370232,
GR-306,
AKOS015951372,
Rifampicin, >=97% (HPLC), powder,
Tox21_111329_1,
BA-411661E,
CCG-208267,
DB01045,
LS-7689,
NCGC00022678-03,
NCGC00022678-04,
NCGC00022678-05,
NCGC00022678-06,
NCGC00179536-02,
NCGC00254537-01,
NCGC00258936-01,
BC205696,
M880,
ST057531,
AB1009526,
C06688,
D00211,
J10110,
Rifampicin, VETRANAL(TM), analytical standard,
AB00383022_07,
292R461,
SR-05000002118,
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin,
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv,
SR-05000002118-3,
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1,
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV,
Rifampicin, European Pharmacopoeia (EP) Reference Standard,
Rifampin, United States Pharmacopeia (USP) Reference Standard,
Rifampin, Pharmaceutical Secondary Standard; Certified Reference Material,
4,7>.0<5,28>]triaconta-1(28),2,4,9,1 9,21,25(29),26-octaen-13-yl acetate,
Rifampicin, plant cell culture tested, BioReagent, >=97% (HPLC), crystalline,
yl]-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-,
(2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-{(E)-[(4-methylpiperazin-1-yl)imino]methyl}-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl ac,
2,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate,
2,7-(epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[(E)-[(4-methyl-1-piperazinyl)imino]meth,
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate,
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (,
2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-, 21-acetate (8CI),
26-[(1E)-2-(4-methylpiperazinyl)-2-azavinyl](7S,11S,13S,17S,18S,12R,14R,15R,16 R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-d ioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<,
5,6,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-(N-(4-methyl-1-piperazinyl)formimidoyl)-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-beta)furan-1,11(2H)-dione 21-acetate,
5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-, 21-acetate,
RMP,
Stereoisomer of 5,9,17,19,21-Hexahydroxy-23-methoxy-2,4,12,16,18,20,22-he@ptamethyl-8-[N-(4-methyl-1-piperazinyl)formimidoyl]-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione 21-acetate,
Ramp,
Rifater,
null,
Refampicin,
Mixture Name,
Rifampicin 1g,
Rifampin/Rifampicin,
RIFAMYCIN,
Unable to generate value,
Rifampicin, 98% - 5G 5g,
D012293,
38776-75-9,
6998-60-3,
Rf,
RIP,
|
| Complexity | 1620 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 9 |
| Defined Bond Stereocenter Count | 4 |
| Exact Mass | 822.405g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 59 |
| Hydrogen Bond Acceptor Count | 15 |
| Hydrogen Bond Donor Count | 6 |
| Isotope Atom Count | 0 |
| Molecular Weight | 822.953g/mol |
| Monoisotopic Mass | 822.405g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 220A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 4.9 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H350-H360 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

